GAM
MRK icon

Groupama Asset Management’s Merck MRK Stock Holding History

Groupama Asset Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$138M Buy
1,063,660
+188,697
+22% +$22.1M 1.73% 15
2026
Q1 		$105M Sell
874,963
-25,823
-3% -$2.98M 1.54% 20
2025
Q4 		$94.8M Buy
900,786
+68,181
+8% +$6.4M 1.39% 18
2025
Q3 		$69.9M Buy
832,605
+49,541
+6% +$4.08M 1.02% 24
2025
Q2 		$61.9M Sell
783,064
-79,295
-9% -$6.3M 1.02% 24
2025
Q1 		$76.9M Buy
862,359
+72,571
+9% +$6.78M 1.54% 16
2024
Q4 		$77.7M Sell
789,788
-764,709
-49% -$78.8M 1.59% 14
2024
Q3 		$69.6M Buy
1,554,497
+144,961
+10% +$17.2M 1.81% 10
2024
Q2 		$87.6M Buy
1,409,536
+713,494
+103% +$91.9M 1.19% 19
2024
Q1 		$98.8M Sell
696,042
-809,347
-54% -$99.8M 1.8% 12
2023
Q4 		$83.1M Buy
+1,505,389
New +$156M 2.16% 9

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Groupama Asset Management's MRK Position: Q2 2026 in Review

Groupama Asset Management increased its Merck (MRK) stake by 22% in Q2 2026, buying an estimated $22.1M and bringing the position to 1,063,660 shares worth $138M. The position accounts for 1.73% of the portfolio, ranked #15.

Groupama Asset Management first reported a position in MRK in Q4 2023 and has held it in 11 quarters since. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Groupama Asset Management held 1,063,660 shares of Merck worth $138M as of Q2 2026.
  • Groupama Asset Management bought 188,697 Merck shares in Q2 2026, an estimated $22.1M.
  • Merck made up 1.73% of Groupama Asset Management's portfolio in Q2 2026, its #15 holding.
  • Groupama Asset Management first reported a position in Merck in Q4 2023 and has held it in 11 quarters since.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Groupama Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.